GENETICALLY PROXIED THERAPEUTIC INHIBITION OF ANTIHYPERTENSIVE DRUG TARGETS AND RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS: A MENDELIAN RANDOMIZATION ANALYSIS

被引：0
|
作者：
Song, S. [1 ]
Wang, C. [2 ]
Zhao, R. [1 ]
Qiao, J. [1 ]
Zhang, S. X. [1 ]
Li, X. [1 ]
机构：
[1] Shanxi Med Univ, Dept Rheumatol, Hosp 2, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Sch Management, Taiyuan, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Systemic lupus erythematosus; Genetics/epigenetics;
D O I：
10.1136/annrheumdis-2023-eular.6051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1427
引用
收藏
页码：1067 / 1067
页数：1
相关论文
共 50 条
  • [1] Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
    Yarmolinsky, James
    Diez-Obrero, Virginia
    Richardson, Tom M.
    Pigeyre, Marie E.
    Sjaarda, Jennifer Y.
    Pare, Guillaume
    Walker, Venexia
    Vincent, Emma
    Tan, Vanessa
    Obon-Santacana, Mireia
    Albanes, Demetrius K.
    Hampe, Jochen
    Gsur, Andrea
    Hampel, Heather
    Pai, Rish
    Jenkins, Mark I.
    Gallinger, Steven
    Casey, Graham M.
    Zheng, Wei
    Amos, Christopher
    Smith, George Davey
    Martin, Richard
    Moreno, Victor
    PRACTICAL consortium
    MEGASTROKE consortium
    PLOS MEDICINE, 2022, 19 (02)
  • [2] Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian randomization analysis
    Yao, Zehui
    Qin, Dailei
    Cao, Jianzhong
    Gao, Chun
    Xi, Pu
    Li, Shengping
    Wei, Ran
    BMC CANCER, 2025, 25 (01)
  • [3] Association between genetically proxied PCSK9 inhibition and systemic lupus erythematosus risk: A mendelian randomization study
    Ji, Xincan
    Guo, Hao-Yang
    Han, Mengqi
    Peng, Hui
    Yuan, Hui
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (04)
  • [4] Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study
    Liang Qiao
    Shun Lv
    Kai Meng
    Jianmei Yang
    Clinical Rheumatology, 2024, 43 : 939 - 947
  • [5] Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study
    Qiao, Liang
    Lv, Shun
    Meng, Kai
    Yang, Jianmei
    CLINICAL RHEUMATOLOGY, 2024, 43 (03) : 1063 - 1071
  • [6] Identification of potential therapeutic targets for systemic lupus erythematosus based on GEO database analysis and Mendelian randomization analysis
    Apaer, Aishanjiang
    Shi, Yanyan
    Aobulitalifu, Alimijiang
    Wen, Fujie
    Muhetaer, Adalaiti
    Ajimu, Nuermaimaiti
    Sulitan, Maierhaba
    Cheng, Lei
    FRONTIERS IN GENETICS, 2024, 15
  • [7] EVALUATING THE IMPACT OF METFORMIN TARGETS ON THE RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS: A MENDELIAN RANDOMIZATION STUDY
    Zheng, L. L.
    Chen, Y. X.
    Wang, C.
    Chang, M. J.
    Zhang, S. X.
    Yu, Q.
    He, P. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1236 - 1237
  • [8] Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study
    Yuan, Shuai
    Burgess, Stephen
    Laffan, Mike
    Mason, Amy M.
    Dichgans, Martin
    Gill, Dipender
    Larsson, Susanna C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (08):
  • [9] ASSESSING THE EFFECT OF ANTIHYPERTENSIVE DRUGS ON SYSTEMIC LUPUS ERYTHEMATOSUS: A MENDELIAN RANDOMIZATION STUDY
    Lu, Y.
    Zhao, Z.
    Song, S.
    Qiao, J.
    Zhang, S. X.
    Li, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1065 - 1065
  • [10] Genetically Proxied Antiplatelet Drug Target Perturbation and Risk of Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Analysis
    Fan, Yu-xiang
    Yang, Cheng-bin
    Song, Zi-hao
    Yang, Xu
    Ma, Yong-jie
    Zhang, Hong-qi
    WORLD NEUROSURGERY, 2025, 196
12345